Chai Phua: 1st Publicly Funded Hemgenix Treatment for Hemophilia B in Canada Marks Historic Gene Therapy Milestone
Chai Phua, Associate Professor at Schulich School of Medicine and Dentistry, shared on LinkedIn:
”A historic milestone for bleeding disorders care in Canada.
Last week, the first publicly funded Canadian patient received Hemgenix for Hemophilia B at London Health Sciences Centre.
While this moment represents a major step forward in gene therapy and hemophilia B care, it also reflects decades of foundational work by leaders, clinicians, researchers, nurses, hemostasis laboratories, blood banks, patient advocates, and the broader bleeding disorders community across Canada who helped build the systems, expertise, and advocacy needed to make innovative therapies like this possible.
Most importantly, this milestone represents hope not only for one patient, but for the future of innovative therapies in rare diseases across Canada.
Thank you to everyone who helped make this possible.”
Stay updated with Hemostasis Today.
-
Jul 11, 2026, 21:11Farjah Algahtani: Learning, Sharing, and Collaborating at ISTH 2026
-
Jul 11, 2026, 19:56Louise St. Germain Bannon: A Fantastic Start to ISTH 2026 and the Future of Thrombosis Research
-
Jul 11, 2026, 19:38Lynn Kloeckner: Recognizing Kirsten Lacine’s Impact on the Stroke Survivor Journey
-
Jul 11, 2026, 19:19Rens De Groot: New Proteomic Evidence Reveals Early Hemolysis During ADAMTS13 Relapse in Immune TTP
-
Jul 11, 2026, 19:01Laurent Bertoletti: Honoring the Legacy of Guy Meyer and the INNOVTE Network at ISTH 2026
-
Jul 11, 2026, 18:53Pilar de la Rocha Mur: Why Trust Is the Most Valuable Currency in Clinical Research
-
Jul 11, 2026, 18:25First Pathogenic Deep-Intronic SERPINC1 Variant Identified in Hereditary Antithrombin Deficiency – JTH
-
Jul 11, 2026, 18:12Dianne E. van der Wal: A Thought-Provoking Discussion on Immunothrombosis at ISTH 2026
-
Jul 11, 2026, 16:07Louise St. Germain Bannon: Where Innovation Meets Collaboration at ISTH 2026